Springthorpe; Brian
Patent Applications and Registrations
Patent applications and USPTO patent grants for Springthorpe; Brian.The latest application filed is for "trisubstituted triazolopyrimidines for use in platelet aggregation inhibition".
Company Profile
0.26.45
- Springthorpe; Brian - Stanford on Soar GB
- Springthorpe; Brian - Cheshire GB
- Springthorpe; Brian - Loughborough GB
- Springthorpe; Brian - Macclesfield GB
- Springthorpe; Brian - Leicestershire GB
- Springthorpe; Brian - Leics GB
- Springthorpe; Brian - Sodertalje SE
- Springthorpe; Brian - Leicestershrie GB
Patent Activity
| Patent | Date |
|---|---|
| Triazolo(4,5-D)pyrimidine compounds Grant RE46,276 - Hardem , et al. January 17, 2 | 2017-01-17 |
| Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition App 20150152111 - Hardern; David ; et al. | 2015-06-04 |
| Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibiton App 20140296258 - Hardern; David ; et al. | 2014-10-02 |
| Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition App 20130109702 - Hardern; David ; et al. | 2013-05-02 |
| Trisubstituted Triazolopyrimidines For Use In Platelet Aggregation Inhibition App 20130072503 - Hardern; David ; et al. | 2013-03-21 |
| Novel Piperidine Derivatives App 20130023562 - Austin; Talbir ; et al. | 2013-01-24 |
| Piperidine derivatives Grant 8,314,127 - Austin , et al. November 20, 2 | 2012-11-20 |
| Novel compounds App 20120165348 - Hardern; David ; et al. | 2012-06-28 |
| Chemical compounds Grant 7,709,500 - Alcaraz , et al. May 4, 2 | 2010-05-04 |
| Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition App 20100069408 - Hardern; David ; et al. | 2010-03-18 |
| Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them App 20090197914 - Cage; Peter ; et al. | 2009-08-06 |
| Chemical Compounds App 20090118513 - Caffrey; Moya ; et al. | 2009-05-07 |
| N-Benzyl-Morpholine Derivatives as Modulators of the Chemokine Receptor App 20090118288 - Luckhurst; Christopher ; et al. | 2009-05-07 |
| Piperidine derivatives useful as modulators of chemokine receptor activity Grant 7,517,989 - Luckhurst , et al. April 14, 2 | 2009-04-14 |
| Piperidine Derivatives Useful as Modulators of Chemokine Receptor Activity App 20090069325 - Luckhurst; Christopher ; et al. | 2009-03-12 |
| Chemical compounds Grant 7,495,013 - Caffrey , et al. February 24, 2 | 2009-02-24 |
| Piperidine derivatives useful as modulators of chemokine receptor activity Grant 7,482,363 - Sanganee , et al. January 27, 2 | 2009-01-27 |
| Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them App 20090023733 - Cage; Peter ; et al. | 2009-01-22 |
| Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them App 20090012125 - Cage; Peter ; et al. | 2009-01-08 |
| Piperidines for the Treatment of Chemokine Mediated Diseases App 20080275084 - Perry; Matthew ; et al. | 2008-11-06 |
| Piperidine Derivatives for the Treatment of Chemokine Mediated Disease App 20080262037 - Mochel; Tobias ; et al. | 2008-10-23 |
| Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition App 20080214812 - Hardern; David ; et al. | 2008-09-04 |
| Novel Piperidine Derivatives App 20080207688 - Austin; Talbir ; et al. | 2008-08-28 |
| Piperidines for the Treatment of Chemokine Mediated Diseases App 20080200505 - Perry; Matthew ; et al. | 2008-08-21 |
| Chemical compounds Grant 7,348,341 - Sanganee , et al. March 25, 2 | 2008-03-25 |
| Piperidine derivatives useful as modulators of chemokine receptor activity Grant 7,307,090 - Evans , et al. December 11, 2 | 2007-12-11 |
| Chemical compounds Grant 7,304,077 - Sanganee , et al. December 4, 2 | 2007-12-04 |
| Preparation of Pharmaceutical Salts of [1,4] - Bipiperidine App 20070276141 - Else; Howard ; et al. | 2007-11-29 |
| Novel compounds App 20070265282 - Hardern; David ; et al. | 2007-11-15 |
| Piperidine derivatives useful as modulators of chemokine receptor activity Grant 7,265,227 - Evans , et al. September 4, 2 | 2007-09-04 |
| Chemical compounds App 20070179297 - Rigby; Aaron ; et al. | 2007-08-02 |
| Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition Grant 7,250,419 - Hardern , et al. July 31, 2 | 2007-07-31 |
| Chemical compounds Grant 7,238,811 - Rigby , et al. July 3, 2 | 2007-07-03 |
| Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity Grant 7,238,691 - Sanganee , et al. July 3, 2 | 2007-07-03 |
| Chemical compound and assay App 20070048215 - Springthorpe; Brian ; et al. | 2007-03-01 |
| Chemical compounds Grant 7,179,922 - Rigby , et al. February 20, 2 | 2007-02-20 |
| Chemical compounds App 20070032523 - Caffrey; Moya ; et al. | 2007-02-08 |
| Piperidine derivatives for the treatment of chemokine or h1 mediated disease state App 20060281726 - Luckhurst; Christopher ; et al. | 2006-12-14 |
| Chemical compounds App 20060264463 - Luckhurst; Christopher ; et al. | 2006-11-23 |
| Cyclopentan-2-ol-1-yl-[1,2,3]triazolo[4,5-D]pyrimidine compounds Grant 7,034,032 - Brown , et al. April 25, 2 | 2006-04-25 |
| Novel piperidine derivatives for use in the treatment of chemokine medicated disease states App 20060040984 - Luckhurst; Christopher ; et al. | 2006-02-23 |
| Novel compounds App 20060025590 - Hardern; David ; et al. | 2006-02-02 |
| Compounds Grant 6,974,868 - Hardern , et al. December 13, 2 | 2005-12-13 |
| Substituted piperidine compounds useful as modulators of chemokine receptor activity App 20050250792 - Thom, Stephen ; et al. | 2005-11-10 |
| Chemical compounds Grant 6,958,350 - Brough , et al. October 25, 2 | 2005-10-25 |
| Piperidine derivatives useful as modulators of chemokine receptor activity App 20050182094 - Sanganee, Hitesh ; et al. | 2005-08-18 |
| Piperidine derivatives useful as modulators of chemokine receptor activity App 20050176708 - Luckhurst, Christopher ; et al. | 2005-08-11 |
| Chemical compounds App 20050171092 - Rigby, Aaron ; et al. | 2005-08-04 |
| Bipiperidine compounds Grant 6,903,115 - Rigby , et al. June 7, 2 | 2005-06-07 |
| Substituted piperidine compounds useful as modulators of chemokine receptor activity Grant 6,903,085 - Thom , et al. June 7, 2 | 2005-06-07 |
| Chemical compounds App 20050107428 - Alcaraz, Lilian ; et al. | 2005-05-19 |
| Piperdine derivatives and their use as modulators of chemokine (especially ccr3) activity App 20040242577 - Sanganee, Hitesh ; et al. | 2004-12-02 |
| Piperidine derivatives useful as modulators of chemokine receptor activity App 20040235894 - Evans, Richard ; et al. | 2004-11-25 |
| Piperidine derivatives useful as modulators of chemokine receptor activity App 20040176411 - Evans, Richard ; et al. | 2004-09-09 |
| Chemical compounds App 20040102483 - Brough, Stephen ; et al. | 2004-05-27 |
| Chemical compounds App 20040102432 - Sanganee, Hitesh ; et al. | 2004-05-27 |
| [1,2,3]-triazolo[4,5-d] pyrimidine compounds Grant 6,713,483 - Guile , et al. March 30, 2 | 2004-03-30 |
| Novel compounds App 20040023988 - Brown, Roger ; et al. | 2004-02-05 |
| Chemical compounds App 20040014783 - Rigby, Aaron ; et al. | 2004-01-22 |
| Chemical compounds App 20040006080 - Rigby, Aaron ; et al. | 2004-01-08 |
| Chemical compounds App 20030166652 - Sanganee, Hitesh ; et al. | 2003-09-04 |
| Novel compounds App 20030144305 - Hardern, David ; et al. | 2003-07-31 |
| Bipiperidine derivatives as modulators of CCR3 activity and as H1 antagonists Grant 6,525,070 - Rigby , et al. February 25, 2 | 2003-02-25 |
| Triazolo(4,5-d)pyrimidine compounds Grant 6,525,060 - Hardern , et al. February 25, 2 | 2003-02-25 |
| Chemical compounds App 20020077337 - Rigby, Aaron ; et al. | 2002-06-20 |
| Triazolo(4,5-d)pyrimidine compounds Grant 6,369,064 - Brown , et al. April 9, 2 | 2002-04-09 |
| Triazolo[4,5-D]pyrimidinyl derivatives and their use as medicaments Grant 6,297,232 - Bonnert , et al. October 2, 2 | 2001-10-02 |
| 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists Grant 6,251,910 - Guile , et al. June 26, 2 | 2001-06-26 |
| Triazolo [4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation Grant 6,156,756 - Hardern , et al. December 5, 2 | 2000-12-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 